Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Robertson

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
Structure-guided design of pyrazolo[1,5-a]pyrimidines as inhibitors of human cyclin-dependent kinase 2Douglas S Williamson, Martin J Parratt, Justin F Bower, et al.
Plos One|May 27, 2014
The hepatoselective glucokinase activator PF-04991532 ameliorates hyperglycemia without causing hepatic steatosis in diabetic ratsDerek M Erion, Amanda Lapworth, Paul A Amor, et al.
Bioorganic & Medicinal Chemistry Letters|January 3, 2012
Fatty acid amide hydrolase inhibitors. 3: tetra-substituted azetidine ureas with in vivo activityStephen D Roughley, Helen Browne, Alba T Macias, et al.
Journal of Medicinal Chemistry|July 25, 2019
Structure-Guided Discovery of a Selective Mcl-1 Inhibitor with Cellular ActivityZoltan Szlávik, Levente Ondi, Márton Csékei, et al.
NPJ Breast Cancer|July 3, 2019
LobSig is a multigene predictor of outcome in invasive lobular carcinomaAmy E McCart Reed, Samir Lal, Jamie R Kutasovic, et al.
Bioorganic & Medicinal Chemistry|September 29, 2012
Targeting conserved water molecules: design of 4-aryl-5-cyanopyrrolo[2,3-d]pyrimidine Hsp90 inhibitors using fragment-based screening and structure-based optimizationNicholas G M Davies, Helen Browne, Ben Davis, et al.
Journal of Medicinal Chemistry|November 19, 2020
Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial ActivityYousuke Yamada, Hajime Takashima, David Lee Walmsley, et al.
Bioorganic & Medicinal Chemistry Letters|October 24, 2012
The design and synthesis of indazole and pyrazolopyridine based glucokinase activators for the treatment of type 2 diabetes mellitusJeffrey A Pfefferkorn, Meihua Tu, Kevin J Filipski, et al.
Journal of Medicinal Chemistry|July 21, 2009
Combining hit identification strategies: fragment-based and in silico approaches to orally active 2-aminothieno[2,3-d]pyrimidine inhibitors of the Hsp90 molecular chaperonePaul A Brough, Xavier Barril, Jenifer Borgognoni, et al.
Journal of Medicinal Chemistry|February 16, 2017
Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate Dehydrogenase KinasePaul A Brough, Lisa Baker, Simon Bedford, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
Structure-guided design of pyrazolo[1,5-a]pyrimidines as inhibitors of human cyclin-dependent kinase 2Douglas S Williamson, Martin J Parratt, Justin F Bower, et al.
Plos One|May 27, 2014
The hepatoselective glucokinase activator PF-04991532 ameliorates hyperglycemia without causing hepatic steatosis in diabetic ratsDerek M Erion, Amanda Lapworth, Paul A Amor, et al.
Bioorganic & Medicinal Chemistry Letters|January 3, 2012
Fatty acid amide hydrolase inhibitors. 3: tetra-substituted azetidine ureas with in vivo activityStephen D Roughley, Helen Browne, Alba T Macias, et al.
Journal of Medicinal Chemistry|July 25, 2019
Structure-Guided Discovery of a Selective Mcl-1 Inhibitor with Cellular ActivityZoltan Szlávik, Levente Ondi, Márton Csékei, et al.
NPJ Breast Cancer|July 3, 2019
LobSig is a multigene predictor of outcome in invasive lobular carcinomaAmy E McCart Reed, Samir Lal, Jamie R Kutasovic, et al.
Bioorganic & Medicinal Chemistry|September 29, 2012
Targeting conserved water molecules: design of 4-aryl-5-cyanopyrrolo[2,3-d]pyrimidine Hsp90 inhibitors using fragment-based screening and structure-based optimizationNicholas G M Davies, Helen Browne, Ben Davis, et al.
Journal of Medicinal Chemistry|November 19, 2020
Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial ActivityYousuke Yamada, Hajime Takashima, David Lee Walmsley, et al.
Bioorganic & Medicinal Chemistry Letters|October 24, 2012
The design and synthesis of indazole and pyrazolopyridine based glucokinase activators for the treatment of type 2 diabetes mellitusJeffrey A Pfefferkorn, Meihua Tu, Kevin J Filipski, et al.
Journal of Medicinal Chemistry|July 21, 2009
Combining hit identification strategies: fragment-based and in silico approaches to orally active 2-aminothieno[2,3-d]pyrimidine inhibitors of the Hsp90 molecular chaperonePaul A Brough, Xavier Barril, Jenifer Borgognoni, et al.
Journal of Medicinal Chemistry|February 16, 2017
Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate Dehydrogenase KinasePaul A Brough, Lisa Baker, Simon Bedford, et al.
Pageof 4